EUVIMEDEUVIMED entdecken
Crossref

Hispolon reduces mitochondrial dysfunction and improves fibrosis of diabetes nephropathy by activating AMPK signal and inhibiting mPTP opening

Yapeng Wang, Ajau Danis, Xueyi Wang, Jia Ren, Teng Ma, Ruixiao Wang

Cellular Signalling · 2025

DOI: 10.1016/j.cellsig.2025.112130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Yapeng Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Ningxia Medical University, Ningxia, China; Department of Basic Science, Faculty of Health Sciences, University Teknologi MARA, Pu…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Mitochondria, Signal Transduction, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Natural Science Foundation of Ningxia Province, Ningxia Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy progression is linked to the AMPK/SIRT1/PGC-1α signaling pathway. Hispolon's potential in improving mitochondrial function and treating diabetic nephropathy via this pathway was unclear. This study used db/db mice and high glucose-induced SV40 MES 13 cells to explore Hispolon's renoprotective mechanisms. In vivo, db/db mice showed glomerular damage, collagen deposition, glycoprotein accumulation, and elevated serum creatinine and urea nitrogen. Hispolon intervention improved these features and parameters. It reduced renal MDA levels, enhanced SOD activity, suppressed pro-inflammatory mediators, and downregulated fibrosis markers. Western blot analysis showed Hispolon restored p-AMPK, SIRT1, and PGC-1α protein levels. In vitro, Hispolon enhanced cell viability, inhibited apoptosis, and reversed high glucose-induced oxidative stress and inflammation in SV40 MES 13 cells. It improved mitochondrial energy metabolism by restoring mitochondrial membrane potential, increasing ATP production, and inhibiting abnormal mPTP opening. Mechanistic studies confirmed that the AMPK/SIRT1/PGC-1α signaling cascade is key for Hispolon's regulation of mPTP dynamics. In conclusion, Hispolon slows diabetic nephropathy progression by activating the AMPK/SIRT1/PGC-1α pathway, inhibiting mPTP opening, and improving mitochondrial dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesMitochondriaSignal TransductionAMP-Activated Protein KinasesAnimalsMiceFibrosisSirtuin 1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaMaleApoptosisOxidative StressMice, Inbred C57BLGlucoseCell LineMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

AMPK/SIRT1/PGC-1αDNHispolonMitochondrial dysfunction

Substanzen

AMP-Activated Protein KinasesSirtuin 1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaGlucosePpargc1a protein, mouse

Autor:innen und Institutionen

  • School of Nursing, Ningxia Medical University, Ningxia, China; Department of Basic Science, Faculty of Health Sciences, University Teknologi MARA, Puncak Alam, Selangor Darul Ehsan, Malaysia.
  • Department of Basic Science, Faculty of Health Sciences, University Teknologi MARA, Puncak Alam, Selangor Darul Ehsan, Malaysia.
  • Department of Emergency Medicine, Traditional Chinese Medicine Hospital of Yinchuan, Ningxia, China.
  • Department of Occupational and Environmental Health, School of Public Health, Ningxia Medical University, Ningxia, China.
  • Department of Acupuncture-Moxibustion and Tuina, People's Hospital of Ningxia Hui Autonomous Region, Ningxia, China.
  • Department of Pathology, General Hospital of Ningxia Medical University, Ningxia, China. Electronic address: docwang1715@nxmu.edu.cn.

Förderung

  • Natural Science Foundation of Ningxia Province
  • Ningxia Medical University

Zitieren

APA

Wang, Y., Danis, A., Wang, X., Ren, J., Ma, T., & Wang, R. (2025). Hispolon reduces mitochondrial dysfunction and improves fibrosis of diabetes nephropathy by activating AMPK signal and inhibiting mPTP opening. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112130

Vancouver

Wang Y, Danis A, Wang X, Ren J, Ma T, Wang R. Hispolon reduces mitochondrial dysfunction and improves fibrosis of diabetes nephropathy by activating AMPK signal and inhibiting mPTP opening. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112130

BibTeX
@article{Wang2025,
  author = {Wang, Yapeng and Danis, Ajau and Wang, Xueyi and Ren, Jia and Ma, Teng and Wang, Ruixiao},
  title = {Hispolon reduces mitochondrial dysfunction and improves fibrosis of diabetes nephropathy by activating AMPK signal and inhibiting mPTP opening},
  journal = {Cellular Signalling},
  year = {2025},
  doi = {10.1016/j.cellsig.2025.112130}
}
Kostenlos starten →